$258 Million is the total value of Wildcat Capital Management, LLC's 16 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KITE | KITE PHARMA INC | $136,014,000 | +0.0% | 2,358,084 | 0.0% | 52.71% | -5.8% | |
| CSGP | COSTAR GROUP INC | $57,657,000 | +7.7% | 291,447 | 0.0% | 22.34% | +1.4% | |
| LPLA | LPL FINANCIAL HOLDINGS INC | $9,064,000 | -1.5% | 206,647 | 0.0% | 3.51% | -7.3% | |
| IAC | IAC/INTERACTIVECORP | $7,658,000 | +11.0% | 113,498 | 0.0% | 2.97% | +4.5% | |
| GASS | STEALTHGAS INC | $6,166,000 | +3.8% | 941,425 | 0.0% | 2.39% | -2.3% | |
| FB | FACEBOOK INCcl a | $507,000 | +5.4% | 6,163 | 0.0% | 0.20% | -1.0% | |
| CMCSK | COMCAST CORPcl a spl | $410,000 | -2.6% | 7,305 | 0.0% | 0.16% | -8.1% | |
| CMCSA | COMCAST CORPcl a | $256,000 | -2.7% | 4,530 | 0.0% | 0.10% | -8.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
| UROGEN PHARMA LTD | 29 | Q2 2024 | 17.3% |
| META PLATFORMS INC | 28 | Q1 2024 | 9.9% |
| ALLOGENE THERAPEUTICS INC | 21 | Q2 2024 | 22.4% |
| GOOSEHEAD INSURANCE INC -A | 21 | Q2 2024 | 15.4% |
| SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
| LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
| PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
| NANTKWEST INC | 17 | Q3 2019 | 22.0% |
| SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Frontier Group Holdings, Inc. | April 08, 2024 | 28,061,351 | 12.6% |
| Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
| UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
| Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
| NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
| Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| SC 13D | 2024-08-22 |
| 3 | 2024-08-15 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 3 | 2024-04-08 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-09 |
| PX14A6G | 2023-11-03 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.